Dr. Pratt is a Ph.D. Medical and Clinical Molecular Geneticist board-certified by the American College of Medical Genetics. Prior to joining Optum Genomics, she was the Laboratory Director of the Pharmacogenomics and Molecular Genetics at Indiana University School of Medicine. She continues to be Adjunct Professor of Medical and Molecular Genetics at Indiana University.
Dr. Pratt is the President of the Association for Molecular Pathology. Dr. Pratt is also the Past Chairs of the Clinical Practice, Program, and Nominations committees, member of the Professional Relations committee and is currently a member of the Economic Affairs committee and chair of the Pharmacogenomics Working Group committees for AMP. She is a former advisor of EurogenTest for genetic test validation. Dr. Pratt served on the American Medical Association’s (AMA) Molecular Pathology Current Procedural Terminology (CPT) Advisory committee. In addition to her work, Dr. Pratt served on the Centers for Medicare and Medicaid Services Clinical Diagnostic Laboratory Tests Advisory Panel. Dr. Pratt continues to serve on the Centers for Disease Control and Prevention (CDC) GeT-RM program for reference materials for Molecular Genetics. She is currently serving on the National Academy of Medicine’s (formerly Institute of Medicine) Roundtable on Genomics and Precision Health. Dr. Pratt has authored over 100 peer-reviewed manuscripts and book chapters. She is also an Associate Editor for the Journal of Molecular Diagnostics. Dr. Pratt graduated with a Ph.D. in Medical and Molecular Genetics from Indiana University School of Medicine, Indianapolis, IN in 1994. Her fellowship training was in Ph.D. Medical and Clinical Molecular Genetics at Henry Ford Hospital, Detroit MI.